Bioinformation · 2020 · 130 citations · 6 references
Life SciencesImmunologyPathologyCellular ImmunologyImmunopathologyInflammationCell-mediated ImmunityCellular Immunity In InfectionCytokine BiologyImmunopathology Of Infectious DiseasesT Cell ActivationT Cell BiologyFlow Cytometry ImmunophenotypingProgrammed Cell Death PathwaysT Cell ImmunologyT Cell-mediated InflammationT Cell-mediated PathologyT-cell BiomarkersT-cell Immune ResponsesT-cell Mediated Inflammation
New evidence on the T-cell immuno-pathology in patient's with Corona Virus Disease 2019 (CoViD-19) was reported by Diao et al. in MedRxiv (doi: 10.1101/2020.02.18.20024364) [1]. It reports observations on 522 patients with confirmed CoViD-19 symptomatology, compared to 40 control subjects. In brief, notable T cytopoenia was recorded by flow cytometry in the CD4+ and the CD8+ populations, which were significantly yet inversely correlated with remarkably increased serum levels of the pro-inflammatory cytokines IL-6, IL-10 and TNF-a. Flow cytometry established a progressive increase in the expression of programmed cell death marker-1 (PD-1) and T cell immunoglobulin and mucin domain 3 (Tim-3) as patients (n=14) deteriorated from prodromal to symptomatic CoViD-19 requiring intensive care. Here, we interpret these observations of Diao et al from our current understanding of T cell immunophysiology and immunopathology following an immune challenge in the form of sustained viral infection, as is the case in CoViD-19, with emphasis on exhausted T cells (Tex). Recent clinical trials to rescue Tex show promising outcomes. The relevance of these interventions for the prevention and treatment of CoViD-19 is discussed. Taken together, the data of Diao et al could proffer the first glimpse of immunopathology and possible immunotherapy for patients with CoViD-19.
6
T cell costimulatory receptor CD28 is a primary target for PD-1–mediated inhibition
Enfu Hui, Jeanne Cheung, Jing Zhu et al. · Science · 2017 · 1.7K citations · Full text
Life Sciences, Immunology, Oncology +17
Rescue of exhausted CD8 T cells by PD-1–targeted therapies is CD28-dependent
Alice O. Kamphorst, Andreas Wieland, Tahseen H. Nasti et al. · Science · 2017 · 1K citations · Full text
Life Sciences, Immunology, Oncology +16
Reduction and Functional Exhaustion of T Cells in Patients with Coronavirus Disease 2019 (COVID-19)
Bo Diao, Chenhui Wang, Yingjun Tan et al. · medRxiv · 2020 · 365 citations · Full text